Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Genetic disorders 7

Genetic Disorders

Pharma News for Aktis, Alcon and Takeda

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Aktis’s Novel Targeted Alpha Radiopharmaceuticals; Koye Partners with Sonde Health; Novartis to Spin Off Sandoz Business; Alcon to Buy Aerie Pharma; Fast Track Designation to Merck’s MK-2060; FDA Approves Ibrutinib for Chronic GvHD; French Authorities Clears BrainVectis’s Clinical Trial; Takeda’s Dengue Vaccine TAK-003 Gets Approval in Indonesia

Aktis Oncology Raises USD 84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals Aktis Oncology has raised an additional USD 84 million in its Series A round, adding to the USD 72 million raised last year to help bring its radiopharmaceuticals to market. The extension to the first round included Merck's venture capital arm and other investors (BMS and Novartis were already on board), bringing the total raised by the Massachusetts biotech to USD 161 million. To deliver highly localized radiotherapy to tumors, Aktis' technology platform employs alpha radiation, which has limited penetrating power. The company's drugs are designed to target receptors on tu...

Explore More...

Epilepsy Market

Ever-evolving Market Dynamics of Epilepsy – a silver lining!

Argininosuccinic aciduria Treatment Market

Argininosuccinic Aciduria Market Awaits Innovative Treatment Expected To Launch In The Next Decade

Down Syndrome Market | Prevalence

Which pipeline therapy has the potential to revolutionize the Down Syndrome Market?

Latest pharma happenings for Roche and Secura Bio

FDA’s Ok to Roche’s Oral SMA Therapy; Roche’s Etrolizumab Mixed Results in Ulcerative Colitis; Secura receives rights to Copiktra from Verastem

Hereditary Transthyretin Amyloidosis Market | hATTR Market Size | hATTR

Unfolding The Folds Of Transthyretin

Adrenoleukodystrophy Market | ALD Market

A Complex Chromosomal Abberation Called Adrenoleukodystrophy

Huntington’s disease Market

Is the cure for Huntington’s disease on the horizon?

Angelman syndrome

Angelman syndrome: A Rare Genetic Disorder

Pharma News

GBT, Syros; Takeda, Cevance collaborates; IND application to ZN-c3

Fragile X Syndrome Market

Fragile X Syndrome Market

UREA CYCLE DISORDER Market

UREA CYCLE DISORDER – A LOST ENZYME may lead to FATAL RISKS

Sickle cell disease treatment

Novel treatment approval promises a better future for Sickle cell disease patients

Beta thalassemia market

How Gene therapy is changing the Beta-thalassemia Treatment outlook?

Pharma news

AbbVie Sells bonds to Fund Allergan takeover

Beta Thalassemia Pharmacological Therapies

Beta-Thalassemia Pharmacological Therapies

Pharma news

FDA declines the approval of Lipocine’s testosterone drug; Novartis Sandoz to buy Aspen Pharmacare Japanese Unit

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly